Mineralocorticoid receptor antagonists for heart failure: systematic review and meta-analysis

Mineralocorticoid receptor antagonists (MRAs) have been associated with improved patient outcomes in patients with heart failure with reduced ejection fraction (HFrEF) but not preserved ejection fraction (HFpEF). We conducted a systematic review and meta-analysis of selective and nonselective MRAs i...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	BMC cardiovascular disorders 2016-12, Vol.16 (1), p.246-246, Article 246
Hauptverfasser:	Berbenetz, Nicolas M, Mrkobrada, Marko
Format:	Artikel
Sprache:	eng
Schlagworte:	Analysis Bias Care and treatment Clinical trials Complications and side effects Diuretics Health aspects Heart failure Heart Failure - drug therapy Heart Failure - physiopathology Hospitalization Hospitalization - trends Humans Meta-analysis Mineralocorticoid Receptor Antagonists - therapeutic use Mineralocorticoids Morbidity Mortality Patient outcomes Stroke Volume - drug effects Studies
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!